Omics in population studies: a molecular epidemiology perspective in chronic airway disease

S. Bonassi (Rome, Italy)

Source: International Congress 2014 – Personalised exposure and gene environment interactions in chronic airway disease: the exposome and epigenome
Disease area: Airway diseases

WebcastSlide presentationMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Bonassi (Rome, Italy). Omics in population studies: a molecular epidemiology perspective in chronic airway disease. International Congress 2014 – Personalised exposure and gene environment interactions in chronic airway disease: the exposome and epigenome

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Small airways and early origins of COPD: pathobiological and epidemiological considerations
Source: Eur Respir J, 55 (3) 1902457; 10.1183/13993003.02457-2019
Year: 2020



The airway ‘resistome’ in chronic respiratory disease: a metagenomics approach
Source: International Congress 2019 – The microbiome: novel data across respiratory diseases
Year: 2019



Mechanisms of COPD exacerbations - molecular perspectives and pathophysiology
Source: ERS Satellites 2021
Year: 2021

Presentation by an expert: Emerging relationships between airway microbiota and chronic respiratory disease : mechanisms of disease onset
Source: Lung Science Conference 2013 - Early origins and mechanisms of chronic lung disease
Year: 2013

Collating data from major European population studies – The CADSET (Chronic airway disease early stratification) clinical research collaboration
Source: Virtual Congress 2020 – New tools for risk stratification of obstructive diseases
Year: 2020




Recommendations for epidemiological studies on COPD
Source: Eur Respir J 2011; 38: 1261-1277
Year: 2011



Introduction “Current perspectives of molecular pathology and functional genomics in neoplastic lung disease”
Source: Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of lung cancer
Year: 2009

Complexity in chronic asthma and COPD: implications for risk assessment, disease progression and control
Source: Annual Congress 2008 - A step-change in asthma. The Lancet/ERS symposium
Year: 2008


Post-genome respiratory epidemiology: a multidisciplinary challenge
Source: Eur Respir J 2004; 24: 471-480
Year: 2004



Epidemiology of COPD: social burden and trends for the future
Source: Annual Congress 2006 - PG13 - COPD: from aetiology to management
Year: 2006



Late Breaking Abstract: An animal model for studies on pathogenesis and pharmaceutical intervention of chronic asthma
Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Year: 2010


Novel insights into the genetics of smoking behaviour, lung function and chronic obstructive pulmonary disease in UK Biobank
Source: International Congress 2015 – Asthma: emerging risk factors and current management of the patient
Year: 2015



The molecular and clinical diseasomeof comorbid diseases inchronic obstructive pulmonary disease
Source: International Congress 2015 – Translational research in respiratory care: new findings
Year: 2015

NOVELTY: a landmark study in phenotyping and endotyping chronic obstructive airway diseases in real clinical practice
Source: Eur Respir J, 58 (3) 2100627; 10.1183/13993003.00627-2021
Year: 2021



Risk factors of chronic airway diseases: population based study
Source: Eur Respir J 2005; 26: Suppl. 49, 140s
Year: 2005

GWA to study the genetics of asthma and in other diseases - advances and challenges
Source: Research Seminar 2009 - Post Genome Respiratory Epidemiology II - An interdisciplinary challenge
Year: 2008



Integrating fingerprints: molecular phenotyping of severe asthma
Source: International Congress 2015 – Fingerprinting severe asthma
Year: 2015